Increased Expression of β-N-Acetylglucosaminidase in Erythrocytes From Individuals With Pre-diabetes and Diabetes

TABLE 1

Baseline characteristics of NIDDK and JH Center subjects. More detailed clinical information of NIDDK samples is provided in the supplemental table in the online appendix.

NIDDK JH Center
Normal Pre-diabetes Type 2 diabetes Normal Diabetes
n 13 13 9 23 44
Age (years) 51.2 ± 6.6 54.5 ± 9.6 53.8 ± 9.2 31 ± 8.2 52.9 ± 12.4
Sex (male/female) 2/11 3/10 4/5 11/12 21/23
Fasting glucose (mg/dl) 87.8 ± 4.2 98.2 ± 9.3 128.9 ± 18.6 NA NA
2-h glucose (mg/dl) 81.0 ± 11.4 166.0 ± 11.7 228.6 ± 28.8 NA NA
Causal glucose NA NA NA 83.1 ± 17.9 154.2 ± 74.1
A1C (%) 5.0 ± 0.3 5.3 ± 0.3 6.1 ± 0.7 5.5 ± 0.4 8.3 ± 1.7
Duration of diabetes (years) NA 15.4 ± 13.9
Type of diabetes (type 1/type 2) 20/24
  • Data are means ± SE. NA, not applicable.

This Article

  1. Diabetes vol. 59 no. 7 1845-1850